🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to estimate the risk of bleeding with rivaroxa...
Status
Completed
Location
Multiple Locations
Start Date
2015-04-20
Trial ID
NCT02293395
Treatments Being Tested
Coronary artery disease (CAD) is a manifestation of systemic atherosclerosi...
Status
Unknown
Location
Radboudumc
Start Date
2022-03-01
Trial ID
NCT05210725
Treatments Being Tested
The study aims to show inferiority of rivaroxaban plus ticagrelor when comp...
Status
Unknown
Location
Multiple Locations
Start Date
2019-10-01
Trial ID
NCT04023630
Treatments Being Tested
In renally impaired patients with acute venous thromboembolism (VTE), stand...
Status
Terminated
Location
CH ARRAS
Start Date
2016-10-19
Trial ID
NCT02664155
Treatments Being Tested
This study investigates the efficacy and safety of direct oral anticoagulan...
Status
Recruiting
Location
Department of Haematology & Transplantology
Start Date
2024-11-22
Trial ID
NCT07270263
Treatments Being Tested
The study will enroll 200 women newly diagnosed with peripartum cardiomyopa...
Status
Recruiting
Location
University of Alabama Birmingham
Start Date
2022-07-27
Trial ID
NCT05180773
This is a phase IV, prospective biomarker study that will be conducted at S...
Status
Unknown
Location
Sinai Hospital of Baltimore
Start Date
2020-01-30
Trial ID
NCT04059679
Treatments Being Tested
The specific mechanistic benefit of rivaroxaban versus other FXa inhibitors...
Status
Completed
Location
Queen Mary Hospital, the University of Hong Kong
Start Date
2021-05-04
Trial ID
NCT06986369
Treatments Being Tested
The primary objectives of this study are: * To determine whether rivaroxab...
Status
Completed
Location
Multiple Locations
Start Date
2013-02-28
Trial ID
NCT01776424
This study aims to evaluate the effects of combination therapy of tegopraza...
Status
Completed
Location
Jeonbuk National University Hospital
Start Date
2023-03-06
Trial ID
NCT05723510
Treatments Being Tested